ArticleJACC. Basic to translational science2023

GLP-1 Receptor Agonists, the Holy Grail Preventing Atrial Fibrillation in Patients With T2D?

Lisa Stoll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.